Somatic Symptoms in Autism Spectrum Disorder: Data Integration
1 other identifier
observational
1,423
0 countries
N/A
Brief Summary
Autistic patients have higher chances commorbid somatic symptoms. Therefore, it leads to more health-related concerns, such as autoimmune disease, gastrointestinal disease, cardiovascular disease, autonomic disorders. On average, autistic patient's life span is 16 years shorter than non-autistic patients. Furthermore, autistic patients are not able to convey or communicate their somatic symptoms in a clear and comprehensive manner. This leads to unable to receive proper health care in a timely manner.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedFirst Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 2, 2023
CompletedJune 2, 2023
June 1, 2022
8.4 years
May 4, 2023
May 23, 2023
Conditions
Outcome Measures
Primary Outcomes (4)
Patient health questionnaire-15, PHQ-15
range from 0 to 2 for each item, total score range from 0 to 30. Higher the score, worse the level of somatization
8 years
Health assessment questionnairse, HAQ
range from 0 to 3 for each item. Higher the score, worse the disability
8 years
Beck depression inventory, BDI
range from 0 to 3 for each item. Higher the score, worse the depression
8 years
Beck anxiety inventory
range from 0 to 3 for each item. Total score 0 to 63. Higher the score, worse the anxiety
8 years
Study Arms (3)
ASD
Diagnosed with DSM-5 autism spectrum disorder
Clinical
Patients with anxiety, depression, somatic symptoms which are non-psychotic and non-organic
Control
Healthy control without psychiatric disorder or chronic somatic symptoms
Interventions
Eligibility Criteria
as mentioned earlier, it is a retrospective study with existed data. Therefore, the 1423 participants are already collected in the past. We separate these existed data into three groups as mentioned in the eligibility criteria
You may qualify if:
- ASD group: diagnosed with DSM-5 autism spectrum disorder
- clinical group: anxiety, depression, somatic disorder who are non-psychotic and non-organic
- control group: healthy control without psychiatric disorder or chronic somatic symptoms
- age between 15 and 70
You may not qualify if:
- psychiatric disorders such as schezophrenia, mood disorder.
- major physical disorder which can be potentially lethal
- who cannot read or comprehend the survey and questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 4, 2023
First Posted
June 2, 2023
Study Start
January 1, 2014
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
June 2, 2023
Record last verified: 2022-06